Fellows' Retina JePARODY -

Name: Fellows' Retina JePARODY
Uploaded: 2022-11-15T05:00:00+00:00
Duration: 1 h 17 min 53 s
Description: Jeopardy® is the iconic trivia game show dating back to the 1960s. This unique and engaging educational activity mimics that familiar format. Spec

Media formats available:

Details

Presenters

Overview
Jeopardy® is the iconic trivia game show dating back to the 1960s. This unique and engaging educational activity mimics that familiar format. Specifically, the game features six retinal disease categories with five questions per category, each with a specific value. The higher the value, the more difficult the question, but also higher the reward! Participants encompass Senior Fellows, Junior Fellows, and Residents.
This content was captured during a live-virtual symposium during which the winners were announced. This on-demand version does not allow real-time participation in the game.
This activity is supported by independent medical education grants from Carl Zeiss Meditec and Regeneron Pharmaceuticals, Inc.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Evaluate the current armamentarium of treatments that are utilized in clinical practice for various retinal diseases
- Discuss how different imaging techniques can aid in the diagnosis of retinal diseases
- Identify how various anatomic, visual, and genetic factors may affect medical and surgical treatment outcomes
- Summarize the therapeutic approaches that are in clinical development for managing retinal diseases, and identify patient cohorts that might benefit the most from these approaches
- Apply case study examples to real-world clinical settings
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Jennifer Kang-Mieler, PhD (Co-Chair)
Chair and Professor
Department of Biomedical Engineering
Stevens Institute of Technology
Hoboken, NJ

William F. Mieler, MD (Co-Chair)
Cless Family Professor and Vice-Chairman of Clinical Affairs
UIC Distinguished Professor
Director, Vitreoretinal Fellowship Training
Department of Ophthalmology & Visual Sciences
University of Illinois at Chicago
Chicago, IL

SriniVas Sadda, MD
Professor of Ophthalmology
Doheny Eye Institute, UCLA
Los Angeles, CA

David Sarraf, MD
Clinical Professor of Ophthalmology
Retinal Disorders and Ophthalmic Genetics Division
Stein Eye Institute, UCLA
Los Angeles, CA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Jennifer Kang-Mieler, PhD (Co-Chair), has had no financial relationships or affiliations with ineligible companies.
William F. Mieler, MD (Co-Chair), has had no financial relationships or affiliations with ineligible companies.
SriniVas Sadda, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alexion, Allergan, Alnylam, Amgen, Apellis Pharmaceuticals, Astellas, Bayer, Biogen, Catalyst Pharma, CenterVue, Genentech/Roche, Heidelberg, Inozyme, Iveric Bio, Notal, Novartis, Oculis, Optos, Oyster Point Pharma, Pfizer, Regeneron, and Thrombogenics/Oxurion. Grant/Research Support: Carl Zeiss Meditec. Research Instruments: Carl Zeiss Meditec, CenterVue, Heidelberg, Nidek, Optos, and Topcon. Speaker's Bureau: Nidek, Novartis, Optos, and Thrombogenics/Oxurion.
David Sarraf, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Bayer, Genentech, Iveric Bio, Novartis, Optovue, and Topcon. Grant/Research Support: Amgen, Boehringer, Genentech, Heidelberg, Optovue, and Regeneron Pharmaceuticals. Speaker's Bureau: Optovue.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Carl Zeiss Meditec, or Regeneron Pharmaceuticals, Inc.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
FOR DUMMIES® is a registered trademark of Wiley Publishing, Inc.
MONSTERS INSIDE ME television series is produced by Optomen Productions.
THE LORD OF THE RINGS is a trademark of The Saul Zaentz Company.
PLAYBOY is a trademark of Playboy Enterprises International Inc.
The CHICAGO MED television series is owned and produced by Wolf Entertainment.
HAMILTON is a trademark of Hamilton IP LLC.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 11/15/2022
Expiration Date: 11/15/2023